Yerong Yu

1.5k total citations
83 papers, 986 citations indexed

About

Yerong Yu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Yerong Yu has authored 83 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Yerong Yu's work include Pituitary Gland Disorders and Treatments (20 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (13 papers). Yerong Yu is often cited by papers focused on Pituitary Gland Disorders and Treatments (20 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (13 papers). Yerong Yu collaborates with scholars based in China, United States and Poland. Yerong Yu's co-authors include Lina Han, Huiwen Tan, Xiaodong Sun, Leilei Zhu, Jiali Liu, Yunxia Zhou, Yige Bao, Hua Li, Hongling Yu and Hongliang Li and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Brain Research.

In The Last Decade

Yerong Yu

79 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yerong Yu China 17 464 230 190 183 178 83 986
C. Cefalo Italy 17 391 0.8× 404 1.8× 255 1.3× 139 0.8× 144 0.8× 47 922
Gerard T. Chew Australia 16 524 1.1× 187 0.8× 320 1.7× 162 0.9× 150 0.8× 23 1.2k
Kuang‐Chung Shih Taiwan 19 330 0.7× 153 0.7× 291 1.5× 166 0.9× 165 0.9× 53 976
Gwanpyo Koh South Korea 17 348 0.8× 167 0.7× 217 1.1× 84 0.5× 127 0.7× 57 939
Anna Leonardini Italy 19 319 0.7× 279 1.2× 443 2.3× 172 0.9× 187 1.1× 25 1.2k
Zoran Gluvić Serbia 20 334 0.7× 145 0.6× 259 1.4× 129 0.7× 197 1.1× 63 1.1k
Katarina Lalić Serbia 16 296 0.6× 168 0.7× 284 1.5× 148 0.8× 196 1.1× 75 1.0k
Linjie Wang China 20 513 1.1× 154 0.7× 294 1.5× 108 0.6× 270 1.5× 120 1.2k
Michela Incani Italy 16 332 0.7× 141 0.6× 111 0.6× 151 0.8× 395 2.2× 26 836
Alexandra Katsimardou Greece 11 403 0.9× 137 0.6× 231 1.2× 174 1.0× 157 0.9× 40 982

Countries citing papers authored by Yerong Yu

Since Specialization
Citations

This map shows the geographic impact of Yerong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yerong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yerong Yu more than expected).

Fields of papers citing papers by Yerong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yerong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yerong Yu. The network helps show where Yerong Yu may publish in the future.

Co-authorship network of co-authors of Yerong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yerong Yu. A scholar is included among the top collaborators of Yerong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yerong Yu. Yerong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimatsu, Akira, Beverly M. K. Biller, Maria Fleseriu, et al.. (2024). Osilodrostat treatment in patients with Cushing’s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4). Endocrine Journal. 71(12). 1103–1123. 9 indexed citations
2.
Chen, Yu, et al.. (2024). Diagnosis and Management of Aggressive/Refractory Growth Hormone‐Secreting Pituitary Neuroendocrine Tumors. International Journal of Endocrinology. 2024(1). 5085905–5085905.
3.
Feldt‐Rasmussen, Ulla, Marek Bolanowski, Shao‐Ling Zhang, et al.. (2024). Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing’s disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study. Frontiers in Endocrinology. 15. 1250822–1250822. 5 indexed citations
4.
5.
Samson, Susan L., Marek Bolanowski, Shao‐Ling Zhang, et al.. (2023). THU054 A Post Hoc Analysis Of The Phase IV B2219 Study To Determine Predictive Factors For Hyperglycemia During Treatment With Pasireotide. Journal of the Endocrine Society. 7(Supplement_1). 2 indexed citations
6.
Gadelha, Mônica R., Marie Bex, Richard A. Feelders, et al.. (2022). Randomized Trial of Osilodrostat for the Treatment of Cushing Disease. The Journal of Clinical Endocrinology & Metabolism. 107(7). e2882–e2895. 66 indexed citations
7.
8.
Wang, Youjuan, et al.. (2021). Elevated thyroid-stimulating hormone levels are associated with poor sleep: a cross-sectional and longitudinal study. Endocrine. 75(1). 194–201. 10 indexed citations
9.
Liu, Hui, et al.. (2021). Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males. Scientific Reports. 11(1). 9495–9495. 3 indexed citations
10.
Chen, Yaxi, et al.. (2020). Detrimental effects of hypercortisolism on brain structure and related risk factors. Scientific Reports. 10(1). 12708–12708. 19 indexed citations
11.
Jia, Wei, Qilin Liu, Yuchun Zhu, et al.. (2019). Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report. BMC Endocrine Disorders. 19(1). 63–63. 10 indexed citations
12.
Lin, Ziqiang, Juan Yang, Hong Liu, et al.. (2018). A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review. Renal Failure. 40(1). 146–151. 8 indexed citations
13.
Jia, Wei, Sheyu Li, Qilin Liu, et al.. (2018). ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures. BMC Endocrine Disorders. 18(1). 22–22. 13 indexed citations
14.
Zhang, Weiwei, Yerong Yu, Huiwen Tan, et al.. (2016). [Value of desmopressin stimulation test and high dose dexamethasone suppression testin the etiologic diagnosis of ACTH dependent Cushing's syndrome].. PubMed. 96(11). 845–9. 2 indexed citations
15.
Zhang, Siqin, et al.. (2016). Lower prevalence of proliferative diabetic retinopathy in elderly onset patients with diabetes. Diabetes Research and Clinical Practice. 125. 47–52. 7 indexed citations
16.
Tan, Huiwen, Chun Wang, & Yerong Yu. (2013). Clinical characteristics and heterogeneity in patients with ketosis-prone diabetes. Zhonghua neifenmi daixie zazhi. 29(12). 1026–1030. 1 indexed citations
17.
Li, Hua, et al.. (2010). Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta. International Journal of Cardiology. 152(2). 218–224. 66 indexed citations
18.
Wang, Chun, et al.. (2010). Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients. Diabetes Research and Clinical Practice. 91(1). 67–71. 8 indexed citations
19.
Wang, Chun, Yi Liu, Yucheng Chen, et al.. (2009). Severe insulin allergy after percutaneous transluminal coronary angioplasty. Clinical Therapeutics. 31(3). 569–574. 1 indexed citations
20.
Yu, Yerong, Yanbing Li, Yangang Wang, et al.. (2003). [Pioglitazone hydrochloride monotherapy or in combination with sulfonylurea therapy improves glycemia control in patients with type 2 diabetes].. PubMed. 34(1). 117–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Cefalo Breakdown of academic impact, for papers by Gerard T. Chew Breakdown of academic impact, for papers by Kuang‐Chung Shih Breakdown of academic impact, for papers by Gwanpyo Koh Breakdown of academic impact, for papers by Anna Leonardini Breakdown of academic impact, for papers by Zoran Gluvić Breakdown of academic impact, for papers by Katarina Lalić Breakdown of academic impact, for papers by Linjie Wang Breakdown of academic impact, for papers by Michela Incani Breakdown of academic impact, for papers by Alexandra Katsimardou
Rankless by CCL
2026